September 23, 2017 11:13 AM ET

Pharmaceuticals

Company Overview of Phibro Animal Health Corporation

Company Overview

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic inte...

Glenpointe Centre East

3rd Floor

Suite 21

300 Frank West Burr Boulevard

Teaneck, NJ 07666

United States

1,400 Employees

Phone:

201-329-7300

Fax:

201-329-7399

Key Executives for Phibro Animal Health Corporation

Chairman, President & CEO
Age: 70
Total Annual Compensation: $2.5M
Chief Financial Officer
Age: 68
Total Annual Compensation: $664.7K
Chief Operating Officer
Age: 53
Total Annual Compensation: $652.7K
Compensation as of Fiscal Year 2016.

Phibro Animal Health Corporation Key Developments

Phibro Animal Health Corporation Announces Improvements in Omnigen-AF Nutritional Specialty Product

Phibro Animal Health Corporation announced it has improved its OmniGen-AF nutritional specialty product to optimize its mixing and handling characteristics when used in feed manufacturing systems and on-farm mixing. Phibro's team of engineering and manufacturing experts have successfully designed and implemented a new proprietary manufacturing process for OmniGen-AF, after several years of development. OmniGen-AF is well known to the global dairy industry as a research-proven product that helps support healthy immune function in dairy cows.

Phibro Animal Health Corporation Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-12-2017 12:20 PM

Phibro Animal Health Corporation Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-12-2017 12:20 PM. Venue: Grand Hyatt New York, 109 E. 42nd Street, New York, New York, United States. Speakers: Richard G. Johnson, Chief Financial Officer.

Phibro Animal Health Corporation Announces Quarterly Dividend

Phibro Animal Health Corporation announced quarterly dividend. The company announced that $4.0 million quarterly dividend paid during the June 2017 quarter - $4.0 million quarterly dividend to be paid September 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 11, 2017
BIOTAY SA
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Phibro Animal Health Corporation, please visit www.pahc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.